| Gregory Joseph Robke, MD | |
|
45 Resnik Road, Suite 302, Plymouth, MA 02360 | |
| (508) 746-2696 | |
| (508) 746-2695 |
| Full Name | Gregory Joseph Robke |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 45 Resnik Road, Plymouth, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003843202 | NPI | - | NPPES |
| 3195104 | Medicaid | MA | |
| J21238 | Other | BCBS | |
| 401728 | Other | TUFTS | |
| 694202 | Other | HPHC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 155581 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna Of Cape Cod | Hyannis, MA | Home health agency |
| Bayada Home Health Care Inc | Plymouth, MA | Home health agency |
| Kindred At Home | Sandwich, MA | Home health agency |
| Bayada Home Health Care , Inc | Hyannis, MA | Home health agency |
| Beacon Hospice, An Amedisys Company | Charlestown, MA | Hospice |
| Vna Of Cape Cod Hospice | South dennis, MA | Hospice |
| Cranberry Hospice | Plymouth, MA | Hospice |
| Beth Israel Deaconess Hospital Plymouth | Plymouth, MA | Hospital |
| Falmouth Hospital | Falmouth, MA | Hospital |
| Cape Cod Healthcare | Hyannis, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Plymouth Bay Internal Medicine | 8224093760 | 2 |
News Archive
Melbourne researchers have been recognised for their major study of injecting drug use and hepatitis C risk in rural Australia.
The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women around the world and achieve the global targets set.
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning in early 2016.
› Verified 2 days ago
| Entity Name | Plymouth Bay Internal Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487783536 PECOS PAC ID: 8224093760 Enrollment ID: O20041124000257 |
News Archive
Melbourne researchers have been recognised for their major study of injecting drug use and hepatitis C risk in rural Australia.
The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women around the world and achieve the global targets set.
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning in early 2016.
› Verified 2 days ago
| Entity Name | Physicians Of Falmouth Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821363698 PECOS PAC ID: 6800051970 Enrollment ID: O20120625000127 |
News Archive
Melbourne researchers have been recognised for their major study of injecting drug use and hepatitis C risk in rural Australia.
The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women around the world and achieve the global targets set.
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning in early 2016.
› Verified 2 days ago
| Entity Name | Physicians Of Cape Cod Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679832364 PECOS PAC ID: 9638326671 Enrollment ID: O20120828000193 |
News Archive
Melbourne researchers have been recognised for their major study of injecting drug use and hepatitis C risk in rural Australia.
The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women around the world and achieve the global targets set.
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning in early 2016.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Joseph Robke, MD 45 Resnik Road, Suite 302, Plymouth, MA 02360 Ph: (508) 746-2696 | Gregory Joseph Robke, MD 45 Resnik Road, Suite 302, Plymouth, MA 02360 Ph: (508) 746-2696 |
News Archive
Melbourne researchers have been recognised for their major study of injecting drug use and hepatitis C risk in rural Australia.
The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women around the world and achieve the global targets set.
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning in early 2016.
› Verified 2 days ago
Dr. Irina Gurevich, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, C/o Cathy Grey, Plymouth, MA 02360 Phone: 508-830-2390 Fax: 508-830-2399 | |
Maysaa El Zoghbi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 508-746-2000 | |
Baigalmaa Enkhtaivan, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 508-830-2679 Fax: 508-830-2702 | |
Senada Arabelovic, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 45 Resnik Rd, Plymouth, MA 02360 Phone: 508-746-5351 | |
Muhammad Mubarak, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 617-754-4677 | |
Katherine Murray Leisure, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 Court St, 3rd Floor, Plymouth, MA 02360 Phone: 508-746-2138 Fax: 508-746-2148 |